These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2894700)

  • 1. Lymphocyte beta-adrenergic receptor binding in panic disorder.
    Brown SL; Charney DS; Woods SW; Heninger GR; Tallman J
    Psychopharmacology (Berl); 1988; 94(1):24-8. PubMed ID: 2894700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte beta-adrenoreceptor density in patients with unipolar depression and normal controls.
    Magliozzi JR; Gietzen D; Maddock RJ; Haack D; Doran AR; Goodman T; Weiler PG
    Biol Psychiatry; 1989 May; 26(1):15-25. PubMed ID: 2541807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte beta-adrenoceptors in social phobia.
    Stein MB; Huzel LL; Delaney SM
    Biol Psychiatry; 1993 Jul 1-15; 34(1-2):45-50. PubMed ID: 8396992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
    Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
    Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells.
    Findell PR; Wong KH; Jackman JK; Daniels DV
    Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    Green SA; Holt BD; Liggett SB
    Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major depression and agoraphobia in patients with angiographically normal coronary arteries and panic disorder.
    Beitman BD; Mukerji V; Lamberti JW; Schmid L; Kushner M
    Can J Psychiatry; 1990 May; 35(4):298-304. PubMed ID: 2346894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of [125I]iodocyanopindolol by rat harderian gland crude membranes: kinetic characteristics and day-night variations.
    Harmouch A; Osuna C; Rafii-el-Idrissi M; Calvo JR; Guerrero JM
    Biosci Rep; 1996 Oct; 16(5):369-77. PubMed ID: 8913527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia.
    Kathol RG; Noyes R; Lopez AL; Reich JH
    Psychiatry Res; 1988 May; 24(2):211-21. PubMed ID: 3406239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding characteristics of 125I-iodocyanopindolol to beta-adrenergic receptors: biphasic Scatchard plots. II. Effects of selective antagonists.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3425-32. PubMed ID: 2892590
    [No Abstract]   [Full Text] [Related]  

  • 11. [The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases].
    Cottraux J; Claustrat B
    Encephale; 1984; 10(6):267-72. PubMed ID: 6529933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
    Bjørnerheim R; Golf S; Hansson V
    Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte beta-adrenergic receptor density of patients with recurrent affective illness.
    Wood K; Whiting K; Coppen A
    J Affect Disord; 1986; 10(1):3-8. PubMed ID: 3009584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.
    Roberts SJ; Molenaar P; Summers RJ
    Br J Pharmacol; 1993 Jun; 109(2):344-52. PubMed ID: 8102926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF prostaglandin-E in agoraphobia with panic attacks.
    Anton RF; Ballenger JC; Lydiard RB; Laraia MT; Howell EF; Gold PW
    Biol Psychiatry; 1989 Jul; 26(3):257-64. PubMed ID: 2545288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic binding of 125I-iodocyanopindolol to beta-adrenergic receptors in rat cerebral cortical membranes. I. Assessment by the use of agonists.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2966-72. PubMed ID: 2890440
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta adrenergic receptors in human cavernous tissue.
    Dhabuwala CB; Ramakrishna CV; Anderson GF
    J Urol; 1985 Apr; 133(4):721-3. PubMed ID: 2858597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors.
    Grunhaus LJ; Cameron O; Pande AC; Haskett RF; Hollingsworth PJ; Smith CB
    Acta Psychiatr Scand; 1990 Mar; 81(3):216-9. PubMed ID: 2160772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects.
    Cameron OG; Smith CB; Lee MA; Hollingsworth PJ; Hill EM; Curtis GC
    Biol Psychiatry; 1990 Jul; 28(1):3-20. PubMed ID: 2165422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet [3H]imipramine binding in patients with panic disorder.
    Uhde TW; Berrettini WH; Roy-Byrne PP; Boulenger JP; Post RM
    Biol Psychiatry; 1987 Jan; 22(1):52-8. PubMed ID: 3790640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.